Results discussion CLA and weight loss Conjugated Linoleic Acid (CLA) is gaining the attention of many nutritionists for its role in weight loss, fighting cancer, building muscles, and preventing diabetes. Early experiments conducted on rodents revealed that the addition of CLA to their daily diet promoted dramatic weight loss. More importantly, the rodents’ lean muscles increased even as they lost body fat. The experiments also revealed that the rodents were less likely to have artery-clogging with CLA in their diet. In the year 2000, research in California was conducted on 17 women involved in having 3 grams of a CLA mixture in their diet every day. After two months, there was no change in their body composition. Since all the participants were required to adhere to a specific diet, there was no way of establishing CLA’s potential to suppress appetite. In another experiment, 21 patients with type II diabetes were subjected to a daily dose of 8 grams of a CLA mixture for two months and with unregulated diets. Their CLA blood levels were then correlated with their weight. The presence of t10c12 isomer signified a weight loss. Effects of adding CLA on food intake With 24 women participants, a randomized, placebo-controlled was conducted to investigate the difference in food intake tendencies when CLA was added to ice cream. The women were divided into two groups; 14 linoleic acid tasters (LAT) and 10 linoleic acid non-tasters (LANT). The groups did not differ in BMI (body mass index), age, or body weight. The test was aimed at establishing the test perception created by CLA, which then affects intake. The results were presented as follows: Eating and appetite profile variables for LAT and LANT                               LAT (n14)     LANT (n 10)                                Mean SD       Mean SD      Meal duration (s)             500.6 156.4   399.9 182.7  Amount eaten (g)              200.5 81.2    175.5 81.9   Amount eaten (Kj)             1316.7 534.1  1140.2 534.5 Eating rate (g/s)             0.4 0.2       0.5 0.2      Bite size (g)                 4.2 1.2       4.8 2.1      Bite frequency (bites per s)  0.1 0.0       0.1 0.0      Satiety                       64.2 14.6     62.8 22.5    Pleasantness of taste         -14.5 12.2    -20.1 10.6    CLA and enzyme activity in the human breast, prostate and colon cancer cells This test was aimed at studying the relationship between CLA isomers and fatty acid synthase (FAS), a fatty acid that cancer cells use to sustain growth. Using SKBr-3, HT-29, and LNCap breast, colon, and prostrate cancer cells respectively, the study was done to establish how CLA isomers inhibit their growth. “The cells proliferation was assessed after 6 days of treatment with CLA isomers” (Lau and Michael 117). The results indicated that CLA inhibited the proliferation of all the cells used in the experiment. The 10,12 CLA isomers inhibited the fatty acid synthase from expressing itself. They also inhibited FAS enzymes activities. From the experiment, the 9,11 isomer inhibited the growth of colon cancer while the 10,12 isomer inhibited the growth of the prostate cancer cells. Discussion Research on the relationship between CLA and weight reveals that there are many disagreements over how exactly CLA fights weight. There is however an agreement that it does reduce the levels of body fat. The experiment done on the 21 patients revealed a significant difference in body fat after having 8 grams included in their d